MEDSTATYBA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 851,312 | 759,669 | 504,757 | 792,719 | 524,344 | 1,005,455 | 991,477 | 976,481 |
| Profit before tax | 143,115 | -135,344 | 7,526 | - | - | - | - | - |
| Net profit | 123,166 | -135,344 | 7,120 | 38,354 | 377 | 173,105 | 83,144 | 103,816 |
| Equity | 1,804,887 | 1,622,349 | 1,629,469 | 1,667,823 | 1,638,200 | 1,786,306 | 1,774,451 | 1,828,267 |
| Liabilities | 144,298 | 38,864 | 32,385 | 49,355 | 40,809 | 115,932 | 42,173 | 15,825 |
| Non-current assets | 775,696 | 770,787 | 739,303 | 565,765 | 519,938 | 555,381 | 514,952 | 451,545 |
| Current assets | 1,173,489 | 890,426 | 922,551 | 1,151,413 | 998,215 | 1,346,857 | 1,301,672 | 1,392,547 |
| Total assets | 1,949,185 | 1,661,213 | 1,661,854 | 1,717,178 | 1,518,153 | 1,902,238 | 1,816,624 | 1,844,092 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 234,755 | 335,461 | 350,935 |
| Social insurance contributions | - | - | - | - | - | 106,774 | 132,530 | 134,567 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +51.1% | -10.8% | -33.6% | +57.0% | -33.9% | +91.8% | -1.4% | -1.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 6.3% | -8.1% | 0.4% | 2.2% | 0.0% | 9.1% | 4.6% | 5.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 6.8% | -8.3% | 0.4% | 2.3% | 0.0% | 9.7% | 4.7% | 5.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 14.5% | -17.8% | 1.4% | 4.8% | 0.1% | 17.2% | 8.4% | 10.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 16.8% | -17.8% | 1.5% | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 42,389 | 38,464 | 26,801 | 45,515 | 35,751 | 67,784 | 52,645 | 56,608 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MEDSTATYBA - Social security debts
The company had no debts to Sodra
MEDSTATYBA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MEDSTATYBA, UAB (code 122603589) is a Private Limited Liability Company engaged in engineering design and construction activities. In 2025, the company generated revenue of €976.5K and net profit of €103.8K, resulting in a 10.6% profit margin. Over the past three years, revenue moved from €1.01M in 2023 to €991.5K in 2024 and €976.5K in 2025, showing a gradual decline. Net profit was €173.1K in 2023, fell to €83.1K in 2024, and recovered in 2025. The 2025 balance sheet remained very conservative, with total assets of €1.84M, equity of €1.83M and liabilities of only €15.8K. This translated into an equity ratio of 99.1% and a debt-to-equity ratio of 0.01. Asset turnover was 0.53x, indicating moderate use of the asset base. Return on equity was 5.7% and return on assets 5.6% in 2025. Revenue per employee stood at €57.4K, while profit per employee was €6.1K.